| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $2.17 (Beat by $0.36) |
| EPS GAAP Actual | $2.17 (Beat by $0.36) |
| Revenue Actual | $5.212B |
| Revenue Surprise | Beat by $5212M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.97311 |
| EPS GAAP Estimate | $1.97311 |
| Revenue Estimate | $5.812853549B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 11.7162 | 7.14 | 11.25073 | 12.3765 | 1 |
| Dec 2028 | 10.2 | 8.2 | 9.85577 | 10.76076 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.63 | -3.44853 | 5.212B | 6.87% | -516.56M |
| FQ2 2025 (Jun 2025) | 1.75 | 0.07966 | 5.208B | 3.01% | -626.8M |
| FQ1 2025 (Mar 2025) | -0.05 | -1.72117 | 4.825B | -1.58% | -579.88M |
| FQ4 2024 (Dec 2024) | 1.14 | 1.14 | 4.907B | -0.24% | 4907M |
| FQ3 2024 (Sep 2024) | 1.48 | 1.48 | 4.854B | -5.36% | 4854M |
| FQ2 2024 (Jun 2024) | 3.47 | 3.47 | 5.051B | -2.95% | 5051M |
| FQ1 2024 (Mar 2024) | 1.62 | 1.62 | 4.901B | 1.69% | 4901M |
| FQ4 2023 (Dec 2023) | 3.22 | 3.22 | 4.919B | 5.67% | 4919M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.97311
Consensus Revenue Estimates
5.812853549B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.5353 | -- | 2.47234 | 2.59016 | 4 |
| FQ3 2027 (Sep 2027) | 2.4254 | -- | 2.36517 | 2.47788 | 4 |
| FQ2 2027 (Jun 2027) | 2.3763 | -- | 2.31729 | 2.42772 | 4 |
| FQ1 2027 (Mar 2027) | 2.1147 | -- | 2.06219 | 2.16046 | 4 |
| FQ4 2026 (Oct 2026) | 2.4501 | -- | 2.34637 | 2.54935 | 5 |
| FQ3 2026 (Jul 2026) | 2.4302 | 167.07 | 2.32731 | 2.52864 | 5 |
| FQ2 2026 (Jun 2026) | 2.219 | 21.14 | 2.10732 | 2.34552 | 5 |
| FQ1 2026 (Mar 2026) | 1.7884 | 102.8 | 1.69839 | 1.89037 | 11 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.78B | -- | 6.65B | 6.89B | 8 |
| FQ3 2027 (Sep 2027) | 6.6B | -- | 6.48B | 6.71B | 5 |
| FQ2 2027 (Jun 2027) | 6.43B | -- | 6.31B | 6.54B | 4 |
| FQ1 2027 (Mar 2027) | 6.26B | -- | 6.14B | 6.37B | 8 |
| FQ4 2026 (Oct 2026) | 6.68B | -- | 6.46B | 6.88B | 10 |
| FQ3 2026 (Jul 2026) | 6.65B | 21.58 | 6.43B | 6.85B | 10 |
| FQ2 2026 (Jun 2026) | 6.69B | 22.18 | 6.43B | 6.99B | 10 |
| FQ1 2026 (Mar 2026) | 6.39B | 24.46 | 6.14B | 6.67B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.81853 | -1.63 | -3.44853 | 211.57% |
| FQ2 2025 (Jun 2025) | 1.67034 | 1.75 | 0.07966 | 4.55% |
| FQ1 2025 (Mar 2025) | 1.67117 | -0.05 | -1.72117 | 3442.34% |
| FQ4 2024 (Dec 2024) | 1.14 | 1.14 | 100% | |
| FQ3 2024 (Sep 2024) | 1.48 | 1.48 | 100% | |
| FQ2 2024 (Jun 2024) | 3.47 | 3.47 | 100% | |
| FQ1 2024 (Mar 2024) | 1.62 | 1.62 | 100% | |
| FQ4 2023 (Dec 2023) | 3.22 | 3.22 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $5.73B | $5.21B | $-516.56M | -9.91% |
| FQ2 2025 (Jun 2025) | $5.83B | $5.21B | $-626.8M | -12.04% |
| FQ1 2025 (Mar 2025) | $5.4B | $4.83B | $-579.88M | -12.02% |
| FQ4 2024 (Dec 2024) | $0B | $4.91B | $4907M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.85B | $4854M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.05B | $5051M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $4.9B | $4901M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.92B | $4919M | 100% |